Low-Dose Computed Tomography Screening: Experiences from the Randomized Population-Based Nelson Screening Trial Rob J. van Klaveren Harry J. de Koning NELSON TRIAL DESIGN The Dutch-Belgian lung cancer screening trial (NELSON)…
Screening for Lung Cancer Claudia I. Henschke David F. Yankelevitz Olli S. Miettinen WHY CONSIDER SCREENING Lung cancer makes, at present, for quite a sad chapter in pulmonary medicine. In…
Population-Based Lung Cancer Prevention: An Overview Anthony W. Kim Mark A. Yoder Michael J. Liptay James L. Mulshine Lung cancer remains the leading cause of cancer-related mortality in the United…
Cell Cycle and Vascular Targets for Radiotherapy Luigi Moretti Sebahat Ocak Dennis E. Hallahan Bo Lu CELL CYCLE TARGETS FOR RADIOTHERAPY The cell cycle checkpoints ensure that cells replicate their…
Mouse Models of Lung Cancer Ambra Pozzi Lung cancer has increased in incidence throughout the 20th century and is now the most common cancer in the Western World. Compared to…
Lung Cancer and Its Microenvironment Marie Wislez Jacques Cadranel Jonathan M. Kurie The association between inflammation and cancer was identified in the 19th century. Initially, it was believed that leukocyte…
Examining the Cancer Stem Cell Hypothesis in Human Lung Cancers Kerstin W. Sinkevicius Stephen J. Curtis Carla F. Kim The cancer stem cell (CSC) hypothesis, which suggests that tumors are…
Applications of Proteomics to the Management of Lung Cancer Pierre P. Massion David P. Carbone Lung cancer is the third most common cancer in the United States, yet it causes…
Molecular Prognostication of Lung Cancer Betty C. Tong David H. Harpole Jr At present, the best prognostic indicator of long-term survival for patients with lung cancer is tumor stage. The…
Molecular Events Surrounding the Angiogenic Switch of Lung Cancer Jair Bar Amir Onn Roy S. Herbst Multicellular organisms such as humans require a complex vascular system to supply cells with…
